Abbott India Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

Jan 06 2026 08:28 AM IST
share
Share Via
Abbott India Ltd. has witnessed a nuanced shift in its technical momentum as of early January 2026, with key indicators signalling a transition from bearish to mildly bearish trends. Despite a modest day gain of 0.37%, the stock’s technical landscape reveals a complex interplay of bullish and bearish signals across weekly and monthly timeframes, prompting a reassessment of its near-term outlook within the Pharmaceuticals & Biotechnology sector.



Technical Trend Overview and Moving Averages


The stock’s overall technical trend has shifted from a clear bearish stance to a mildly bearish one, reflecting a subtle improvement in price momentum. Daily moving averages remain bearish, indicating that short-term price action is still under pressure. Abbott India’s current price stands at ₹28,194, slightly above the previous close of ₹28,090, but well below its 52-week high of ₹35,921.55. The 52-week low is ₹25,260.20, suggesting the stock is trading closer to its lower range than its peak over the past year.


Moving averages, particularly the 50-day and 200-day, continue to exert downward pressure, signalling that the stock has yet to establish a sustained uptrend. This bearish posture on the daily chart contrasts with some weekly and monthly indicators, which show signs of tentative recovery or neutral momentum.



MACD and RSI: Divergent Signals


The Moving Average Convergence Divergence (MACD) indicator presents a mixed picture. On a weekly basis, the MACD remains bearish, suggesting that momentum is still tilted towards sellers in the medium term. However, the monthly MACD has improved to a mildly bearish stance, indicating a potential easing of downward momentum over a longer horizon.


Conversely, the Relative Strength Index (RSI) on the weekly chart has turned bullish, signalling that the stock may be gaining upward momentum in the short to medium term. The monthly RSI, however, remains neutral with no clear signal, reflecting indecision among investors over the longer term. This divergence between weekly bullish RSI and monthly neutral RSI highlights the stock’s current technical uncertainty.



Bollinger Bands and KST Indicator Insights


Bollinger Bands add further nuance to the technical outlook. On a weekly basis, the bands indicate a mildly bearish trend, with the stock price hovering near the lower band, which often suggests oversold conditions but also persistent downward pressure. The monthly Bollinger Bands remain bearish, reinforcing the longer-term caution among market participants.


The Know Sure Thing (KST) indicator offers a more optimistic view on the weekly timeframe, showing a mildly bullish signal. This suggests that momentum could be building for a potential rebound in the near term. However, the monthly KST remains mildly bearish, consistent with other monthly indicators that caution against premature optimism.




Strong fundamentals, solid momentum, fair price – This Large Cap from the NBFC sector checks every box for our Top 1%. This should definitely be on your radar!



  • - Complete fundamentals package

  • - Technical momentum confirmed

  • - Reasonable valuation entry


Add to Your Radar Now →




Volume and Trend Confirmation Indicators


On-Balance Volume (OBV) readings for Abbott India show no clear trend on both weekly and monthly charts, indicating that volume is not currently confirming either a strong buying or selling momentum. Similarly, Dow Theory analysis reveals no definitive trend on weekly or monthly timeframes, underscoring the stock’s technical indecision.


These neutral volume and trend confirmation signals suggest that while price movements have shown some improvement, investor conviction remains tentative. This lack of volume support could limit the sustainability of any short-term rallies.



Comparative Performance Against Sensex


Abbott India’s recent returns have lagged behind the broader market benchmark, the Sensex, across multiple time horizons. Over the past week, the stock declined by 2.49% compared to the Sensex’s 0.88% gain. Similarly, the one-month return was down 2.34%, while the Sensex fell marginally by 0.32%. Year-to-date, Abbott India is down 3.01%, whereas the Sensex has advanced 0.26%.


Over longer periods, the stock’s performance remains mixed. The one-year return of -4.21% contrasts with the Sensex’s robust 7.85% gain. However, Abbott India has outperformed the Sensex over five and ten-year periods, delivering returns of 80.47% and 379.08% respectively, compared to the Sensex’s 76.39% and 234.01%. This long-term outperformance highlights the company’s resilience despite recent technical challenges.



Mojo Score and Rating Upgrade


MarketsMOJO has upgraded Abbott India’s Mojo Grade from Sell to Hold as of 29 December 2025, reflecting the evolving technical and fundamental outlook. The current Mojo Score stands at 50.0, signalling a neutral stance. The Market Cap Grade remains low at 2, indicating limited market capitalisation strength relative to peers.


This upgrade to Hold suggests that while the stock is not yet a clear buy, it has improved sufficiently to warrant cautious consideration by investors. The mixed technical signals and modest price momentum support this balanced rating.




Holding Abbott India Ltd. from Pharmaceuticals & Biotechnology? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!



  • - Peer comparison ready

  • - Superior options identified

  • - Cross market-cap analysis


Switch to Better Options →




Investor Takeaway and Outlook


Abbott India Ltd. currently presents a technically cautious picture with a mildly bearish overall trend but pockets of bullish momentum emerging on shorter timeframes. The weekly RSI and KST indicators suggest potential for a near-term rebound, yet the persistent bearish signals from moving averages, MACD, and Bollinger Bands on monthly charts counsel prudence.


Investors should weigh the stock’s recent underperformance against the Sensex and the absence of strong volume confirmation before committing to new positions. The upgrade to a Hold rating by MarketsMOJO reflects this balanced view, recommending monitoring for clearer trend confirmation before increasing exposure.


Long-term investors may find comfort in Abbott India’s solid historical returns over five and ten years, but short-term traders should remain alert to volatility and mixed technical signals.



Summary of Key Technical Metrics:



  • Current Price: ₹28,194.00 (up 0.37% on the day)

  • 52-Week Range: ₹25,260.20 – ₹35,921.55

  • Moving Averages (Daily): Bearish

  • MACD: Weekly Bearish, Monthly Mildly Bearish

  • RSI: Weekly Bullish, Monthly Neutral

  • Bollinger Bands: Weekly Mildly Bearish, Monthly Bearish

  • KST: Weekly Mildly Bullish, Monthly Mildly Bearish

  • OBV and Dow Theory: No clear trend

  • Mojo Grade: Hold (Upgraded from Sell on 29 Dec 2025)

  • Mojo Score: 50.0



Given these factors, Abbott India remains a stock to watch closely as technical momentum evolves in the coming weeks.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Abbott India Ltd. is Rated Hold
Jan 04 2026 10:10 AM IST
share
Share Via
Abbott India Ltd. is Rated Sell
Dec 24 2025 08:23 PM IST
share
Share Via
Why is Abbott India falling/rising?
Dec 09 2025 12:47 AM IST
share
Share Via